Loading…

Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation

The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2010-05, Vol.20 (9), p.2933-2937
Main Authors: Ye, Xiang-Yang, Chen, Stephanie, Zhang, Hao, Locke, Kenneth T, O'Malley, Kevin, Zhang, Litao, Srivastava, Raijit, Miao, Bowman, Meyers, Daniel, Monshizadegan, Hossain, Search, Debra, Grimm, Denise, Zhang, Rongan, Lippy, Jonathan, Twamley, Celeste, Muckelbauer, Jodi K, Chang, Chiehying, An, Yongmi, Hosagrahara, Vinayak, Zhang, Lisa, Yang, T-J, Mukherjee, Ranjan, Cheng, Peter T W, Tino, Joseph A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.
ISSN:1464-3405
DOI:10.1016/j.bmcl.2010.03.019